Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-07

Clinical Trial Update: A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexmedetomidine hydrochloride nasal spray for preoperative sedation in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine hydrochloride nasal spray (dexmedetomidine)

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Preoperative Sedation of Children | Phase 3 | Status: COMPLETED